Michael Radin, based in Plainsboro, New Jersey, United States, is currently a Executive Director at Novo Nordisk, bringing experience from previous roles at Novo Nordisk, Nyu Long Island School of Medicine, Stony Brook University School of Medicine and Sanofi. Michael Radin holds a 2002 - 2005 University of Pittsburgh School of Medicine. With a robust skill set that includes Clinical Research, Diabetes, Clinical Trials, Endocrinology, Medicine and more, Michael Radin contributes valuable insights to the industry. Michael Radin has 1 email on RocketReach.